Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Noninvasive Glucose Monitors Inching Toward Commercialization

Greystone Associates
Posted on: 26 Nov 04

Slowed by Financial Constraints, a Host of Small Companies Push Patient-friendly Monitor Technologies


(  But while the traditional finger prick method has been a standard disease management tool for decades, issues of patient compliance and the limitations of current methods in detecting short-term fluctuations in glucose levels have brought a host of companies into the hunt for noninvasive alternatives. These companies are competing for a share of a $5 billion world market for glucose monitoring, a market that is expected to grow at a significant rate for the rest of the decade.


Advances in sensing electronics and signal processing are paving the way for glucose monitors that have the potential to eliminate the need for invasive blood sampling. Noninvasive monitors winding their way through the development and clinical trial process include novel optical, RF, and thermal designs. “The ability to monitor glucose levels in a painless and consistent way has the potential to improve the quality of life for millions of diabetes patients,” explains George Perros, Greystone Managing Director. “It’s a daunting technical challenge that must take into account the user needs of patients across a broad socioeconomic spectrum. These monitors must be extremely accurate and reliable, and usable by almost anyone.  Successful companies will be those that have the ability to attract and manage financial resources over a protracted product development cycle.”


These findings are contained in a new and comprehensive report: Noninvasive Glucose Monitors: Technology, Players and Prospects. The report includes a comprehensive assessment of current and planned noninvasive glucose monitoring products, profiles of market participants, noninvasive technology evaluations and risk factors, revenue forecasts, and detailed analysis of regulatory and market factors.


More information is available at .


About Greystone


Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology and market assessment.




Mark Smith

Voice: 603-595-4340

Fax: 603-804-0466                                         Source: Greystone Associates


For more information:

Editor's Details

Mark Smith
Greystone Associates

Last updated on: 27/08/2010

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.